Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback